Current Edition

neuroendocrine

RadioMedix, Areva Med begin phase 1 trial of AlphaMedix to treat neuroendocrine tumours

RadioMedix,a clinical stage biotechnology company, and Areva Med, a nuclear biotech company, have announced the initiation in the United States of phase 1 trial for …

Continue Reading →